NOLVADEX

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Malta, Mexico, Poland, Singapore, South Africa.

Active ingredients

The drug NOLVADEX contains one active pharmaceutical ingredient (API):

1	Tamoxifen UNII 7FRV7310N6 - TAMOXIFEN CITRATE
	Tamoxifen is a non-steroidal, triphenylethylene-based drug which displays a complex spectrum of oestrogen antagonist and oestrogen agonist-like pharmacological effects in different tissues.
	Read more about Tamoxifen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NOLVADEX D Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02BA01	Tamoxifen	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BA Anti-estrogens
Discover more medicines within L02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10911G, 1880Y
BR	Câmara de Regulação do Mercado de Medicamentos	502302802116315, 502302901114310
CA	Health Products and Food Branch	02048485
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02793861
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	675-MEE-0115
EE	Ravimiamet	1002665
FR	Base de données publique des médicaments	60328432, 61961476
HK	Department of Health Drug Office	19529
HR	Agencija za lijekove i medicinske proizvode	HR-H-544415146
IE	Health Products Regulatory Authority	36927
IT	Agenzia del Farmaco	023362039, 023362041
JP	医薬品医療機器総合機構	4291003F1163, 4291003F2054
MT	Medicines Authority	MA046/02101, PI908/19001A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	90749
PL	Rejestru Produktów Leczniczych	100047984
SG	Health Sciences Authority	00794P, 00796P
ZA	Health Products Regulatory Authority	S/21.12/41